What causes herpes, and how can you treat it? - Christine Johnston

Key Concepts

• Herpes Simplex Virus (HSV): A family of viruses, with HSV-1 and HSV-2 being the primary causes of herpes infections.
• HSV-1: Typically associated with oral herpes (cold sores).
• HSV-2: More commonly associated with genital herpes.
• Latency: The ability of HSV to remain dormant within nerve cells (ganglia), evading the immune system.
• Ganglia: Clusters of nerve cells where HSV establishes latency (trigeminal for HSV-1, sacral for HSV-2).
• Reactivation: The process by which the dormant virus re-emerges, causing recurrent symptoms.
• Antiviral Medications: Treatments that inhibit viral replication, reducing symptom severity and transmission risk.

Historical Context & Prevalence

In the 1st century CE, Roman Emperor Tiberius instituted a ban on kissing at public events, believed to be a response to an outbreak of oral herpes. Today, over half the global population is infected with herpes simplex virus (HSV), with an estimated 90% unaware of their infection status. The term “herpesvirus” encompasses an entire family of viruses, but the condition commonly referred to as “herpes” is primarily caused by HSV-1 and HSV-2.

Viral Characteristics & Infection Process

While HSV-1 and HSV-2 share similarities, they typically infect different areas. HSV-1 is predominantly linked to oral herpes, manifesting as cold sores around the mouth. Genital herpes can be caused by either virus, though HSV-2 is the more frequent culprit. However, both viruses can infect other body parts, including fingers and eyes.

Infection occurs through microscopic breaks in the skin or mucous membranes, such as those found in the mouth and genitals. Once inside, the virus hijacks the host cell’s machinery to replicate and spread. Initial infections may be asymptomatic, but can also cause fluid-filled blisters that rupture into painful lesions. Severe initial infections can lead to systemic symptoms like fever, muscle aches, and headaches.

Immune Response & Viral Latency

The body’s immune system responds to the viral onslaught, attempting to eliminate HSV, similar to its response to other viral pathogens. However, HSV’s unique ability to establish latency makes complete eradication difficult. The virus infiltrates nearby nerve cells and travels along axons to nerve clusters called ganglia. HSV-1 preferentially resides in the trigeminal ganglia located in the skull, while HSV-2 favors the sacral ganglia near the base of the spinal cord.

Within the ganglia, the virus enters a dormant state, effectively shutting down its replication machinery to avoid immune detection. This latency doesn’t eliminate the virus, but renders it undetectable and symptom-free.

Viral Reactivation & Transmission

The dormant virus can periodically reactivate, often triggered by factors like illness or stress, though the exact cause isn’t always known. Upon reactivation, the virus travels back along the nerve to the skin surface, potentially causing itching or tingling – often the first sign of recurrence. Replication resumes, leading to a new outbreak of symptoms. Recurrences vary in frequency, ranging from monthly to every few years.

The virus is transmissible to others through direct contact during active shedding, even in the absence of visible sores. The high prevalence of asymptomatic infections contributes to the widespread transmission of HSV.

Diagnosis & Treatment

Diagnosing herpes can be challenging. Blood tests are often inaccurate and cannot reliably differentiate between oral and genital HSV-1 infections. The most accurate diagnosis involves a healthcare provider examining a lesion during an active outbreak.

Treatment primarily focuses on managing symptoms. Antiviral medications work by mimicking viral DNA components and inhibiting viral replication. These medications can also reduce the risk of HSV-2 transmission by approximately 50%. Over time, the frequency and severity of outbreaks typically decline as the body develops some immunity, though the risk of recurrence and transmission remains.

Ongoing Research & Future Prospects

Despite decades of research, a cure for herpes remains elusive due to the virus’s ability to establish silent infections and evade the immune system. However, emerging technologies like gene editing and novel vaccine development offer promising avenues for future treatments aimed at preventing or curing herpes. As stated implicitly throughout the video, the stealthy nature of the virus presents a significant challenge to researchers.